177 related articles for article (PubMed ID: 20387390)
21. [The effect of semax and its C-end peptide PGP on Vegfa gene expression in the rat brain during incomplete global ischemia].
Stavchanskiĭ VV; Tvorogova TV; Botsina AIu; Limborskaia SA; Skvortsova VI; Miasoedov NF; Dergunova LV
Mol Biol (Mosk); 2013; 47(3):461-6. PubMed ID: 23888777
[TBL] [Abstract][Full Text] [Related]
22. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
[TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin tetrapeptide effects on HPA axis function and elevated plus maze behaviour in maternally separated and handled rats.
Greisen MH; Bolwig TG; Wörtwein G
Behav Brain Res; 2005 Jun; 161(2):204-12. PubMed ID: 15922046
[TBL] [Abstract][Full Text] [Related]
24. [Neonatal Semax and saline injections induce open-field behavior changes in mice of different genotypes].
Shilova OB; Markina NV; Perepelkina OV; Gichenok IV; Korochkin LI; Poletaeva II
Zh Vyssh Nerv Deiat Im I P Pavlova; 2004; 54(6):785-94. PubMed ID: 15658043
[TBL] [Abstract][Full Text] [Related]
25. Effects of behaviorally active ACTH (4-10) analogue - Semax on rat basal forebrain cholinergic neurons.
Grivennikov IA; Dolotov OV; Zolotarev YA; Andreeva LA; Myasoedov NF; Leacher L; Black IB; Dreyfus CF
Restor Neurol Neurosci; 2008; 26(1):35-43. PubMed ID: 18431004
[TBL] [Abstract][Full Text] [Related]
26. [POSSIBLE ROLE OF TRANSTHYRETIN IN THE BIOLOGICAL MECHANISM OF THE REGULATORY PEPTIDE NEUROPROTECTION.].
Vyunova TV; Medvedeva EV; Andreeva LA; Dergunova LV; Limborska SA; Myasoedov NF
Mol Gen Mikrobiol Virusol; 2016; 34(3):104-109. PubMed ID: 30383932
[TBL] [Abstract][Full Text] [Related]
27. Brain Protein Expression Profile Confirms the Protective Effect of the ACTH
Sudarkina OY; Filippenkov IB; Stavchansky VV; Denisova AE; Yuzhakov VV; Sevan'kaeva LE; Valieva LV; Remizova JA; Dmitrieva VG; Gubsky LV; Myasoedov NF; Limborska SA; Dergunova LV
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201112
[TBL] [Abstract][Full Text] [Related]
28. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
[TBL] [Abstract][Full Text] [Related]
29. [Effect of semax on the temporary dynamics of brain-derived neurotrophic factor and nerve growth factor gene expression in the rat hippocampus and frontal cortex].
Agapova TIu; Agniullin IaV; Silachev DN; Shadrina MI; Slominskiĭ PA; Shram SI; Limborskaia SA; Miasoedov NF
Mol Gen Mikrobiol Virusol; 2008; (3):28-32. PubMed ID: 18756821
[TBL] [Abstract][Full Text] [Related]
30. [Formation of the spatial memory in rats with ischemic injury in prefrontal areas of the cortex--effects of a sinthetic analogue of ACTH(4-7)].
Silachev DN; Shram SI; Shakova FM; Romanova GA; Miasoedov NF
Zh Vyssh Nerv Deiat Im I P Pavlova; 2008; 58(4):458-66. PubMed ID: 18825944
[TBL] [Abstract][Full Text] [Related]
31. Semax, an analog of ACTH
Medvedeva EV; Dmitrieva VG; Limborska SA; Myasoedov NF; Dergunova LV
Mol Genet Genomics; 2017 Jun; 292(3):635-653. PubMed ID: 28255762
[TBL] [Abstract][Full Text] [Related]
32. [Effects of neonatal fluvoxamine administration to white rats and their correction by semax treatment].
Volodina MA; Merchieva SA; Sebentsova EA; Glazova NIu; Manchenko DM; Andreeva LA; Levickaia NG; Kamenskiĭ AA; Miasoedov NF
Izv Akad Nauk Ser Biol; 2014; (4):391-7. PubMed ID: 25735182
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced suppression of ACTH secretion does not promote anti-depressive or anxiolytic effects.
Ramos Ade T; Homem KS; Suchecki D; Tufik S; Troncone LR
Behav Brain Res; 2014 May; 265():69-75. PubMed ID: 24569014
[TBL] [Abstract][Full Text] [Related]
34. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
Netto CF; Guimarães FS
Neuropsychopharmacology; 2004 Jan; 29(1):101-7. PubMed ID: 14583742
[TBL] [Abstract][Full Text] [Related]
35. Possible mechanism underlying the effect of Semax on the formation of indomethacin-induced ulcers in rats.
Zhuikova SE; Sergeev VI; Samonina GE; Myasoedov NF
Bull Exp Biol Med; 2002 Jun; 133(6):577-9. PubMed ID: 12447470
[TBL] [Abstract][Full Text] [Related]
36. [Study of neuroprotective, antihypoxic and antiamnesic effects of new mixture of tripeptides].
Iasnetsov VV; Chertorizhskiĭ EA; Belyĭ PA; Bespalova ZhD; Ovchinnikov MV; Vereshchagina AO; Ivanov IuV; Iasnetsov VV; Kirsanova SK; Motin VG
Eksp Klin Farmakol; 2015; 78(1):3-8. PubMed ID: 25826866
[TBL] [Abstract][Full Text] [Related]
37. Effect of Semax peptide on survival of cultured rat pheochromocytoma cells during oxidative stress.
Safarova ER; Shram SI; Zolotarev YA; Myasoedov NF
Bull Exp Biol Med; 2003 Mar; 135(3):268-71. PubMed ID: 12802399
[TBL] [Abstract][Full Text] [Related]
38. [Effect of semax and its mixture with heparin on the activity of isolated heart after total ischemia].
Orlov AV; Khomutov AE; Mukhina IV; Zimin IuV; Parin SB; Kozin DV
Biull Eksp Biol Med; 1999 Nov; 128(11):494-6. PubMed ID: 10640229
[No Abstract] [Full Text] [Related]
39. Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze.
Alcalay RN; Giladi E; Pick CG; Gozes I
Neurosci Lett; 2004 May; 361(1-3):128-31. PubMed ID: 15135910
[TBL] [Abstract][Full Text] [Related]
40. [Chronotropic activity of semax].
Arushanian EB; Popov AV
Eksp Klin Farmakol; 2008; 71(2):14-6. PubMed ID: 18488900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
